Xintela AB (publ) (STO:XINT)
0.260
+0.013 (5.26%)
At close: Mar 6, 2026
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 223.93 million as of March 6, 2026. Its market cap has increased by 0.95% in one year.
Market Cap
223.93M
Enterprise Value
200.72M
Revenue
2.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 223.93M, an increase of 115.98%. That is a compound annual growth rate of 8.04%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intervacc AB | 229.71M |
| AlzeCure Pharma AB | 217.76M |
| Initiator Pharma | 204.67M |
| Sprint Bioscience AB | 198.90M |
| Isofol Medical AB | 194.67M |
| Mendus AB | 258.28M |
| Lipum AB | 304.40M |
| Magle Chemoswed Holding AB | 161.07M |